AGA Medical Holdings, which makes minimally invasive devices to treat heart defects and vascular diseases, lowered the proposed deal size for its upcoming IPO on Tuesday. The Plymouth, MN-based company now plans to raise $213 million by offering the same 13.8 million shares at a price range of $15.00 to $16.00. The company had previously filed at a range of $19.00 to $21.00. At the mid-point of the revised range, AGA Medical Holdings will raise -23% fewer proceeds than previously anticipated. AGA Medical Holdings, which was founded in 1995 and booked $180 million in sales over the last 12 months, plans to list on the NASDAQ under the symbol AGAM. BofA Merrill Lynch, Citi, and Deutsche Bank are the lead underwriters on the deal, which is expected to price later tonight.
